
Linear Therapies is a biotechnology company developing a pan-viral treatment and prevention platform using AI-powered siRNA technology to target highly conserved viral mRNA regions. Their platform enables rapid discovery and optimization of antiviral therapeutics, including a potent anti-COVID candidate, delivered via inhalation for fast, reliable protection. The company collaborates with government agencies and leverages advanced molecular compounds and lipid nanoparticles for effective RNA stability and delivery, positioning itself as a key player in pandemic threat response and antiviral drug development.

Linear Therapies is a biotechnology company developing a pan-viral treatment and prevention platform using AI-powered siRNA technology to target highly conserved viral mRNA regions. Their platform enables rapid discovery and optimization of antiviral therapeutics, including a potent anti-COVID candidate, delivered via inhalation for fast, reliable protection. The company collaborates with government agencies and leverages advanced molecular compounds and lipid nanoparticles for effective RNA stability and delivery, positioning itself as a key player in pandemic threat response and antiviral drug development.